ArticleScientific reports2025
Cobalt-nickel supported on magnetic mesoporous silica hollow spheres for efficient synthesis of tetrazole derivatives under solvent-free conditions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study presents the synthesis and characterization of a Co-Ni anchored magnetic mesoporous silica hollow sphere as an efficient and eco-friendly nanocatalyst for the preparation of 1-substituted 1H-1,2,3,4-tetrazole derivatives. The hollow and mesoporous architecture of the catalyst provides a large active surface area, enhancing its catalytic performance. The synergistic interaction between cobalt and nickel on the catalyst surface significantly improves its efficiency. The catalyst was thoroughly characterized using FT-IR, XRD, FE-SEM, TEM, EDS, elemental mapping, BET, ICP-OES and VSM techniques. Its magnetic properties facilitate easy separation and recyclability, with minimal loss of activity over multiple cycles. The nanocatalyst was applied in a solvent-free, three-component reaction involving triethyl orthoformate, sodium azide, and aromatic amines at 80 °C, affording the desired 1-substituted tetrazole derivatives in excellent yields (up to 98%). Reaction parameters, including catalyst loading, temperature, and solvent effects were optimized. Additionally, the obtained tetrazole derivatives were identified by their melting points, FT-IR,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.